Literature DB >> 9865431

Chromosome 8, occupational exposures, smoking, and acute nonlymphocytic leukemias: a population-based study.

L Davico1, C Sacerdote, G Ciccone, L Pegoraro, S Kerim, G Ponzio, P Vineis.   

Abstract

In a previous epidemiological study on acute myelocytic leukemia (M. M. Crane et al., Cancer Epidemiol. Biomark. Prev., 5: 639-644, 1996), clonal aberrations in chromosome 8 have been reported to be in excess in smokers and in workers exposed to paints. In that study, cytogenetics was performed after therapy. In our report, we describe a population-based survey on nonlymphocytic leukemias in northern Italy, in which 79 patients (acute myelocytic leukemia, myelodysplastic syndromes, or other nonlymphocytic leukemias) were studied before cytotoxic therapy. We found 9 aberrations involving chromosome 8 (six +8, two -8, and one translocation), whereas abnormalities involving chromosomes 5 and 7 occurred with a low frequency compared with previous studies. Aberrations involving chromosome 8 were associated with smoking (odds ratio, 6.3; 95% confidence interval, 0.9-42.3; among smokers of 10 or more cigarettes/day: odds ratio, 14.2; 95% confidence interval, 1.4-142.3); +8 aberrations were found in 1 of 24 nonsmokers and in 5 of 38 smokers. Three +8 aberrations were found in 22 subjects potentially exposed to solvents or polycyclic aromatic hydrocarbons. The low frequency of chromosome 5 and 7 aberrations in our population-based series (compared with other studies) can be attributed to the recruitment before cytotoxic therapies. Aberrations involving chromosome 8 (particularly +8) were associated with smoking habits. Chromosome 8 includes the c-myc oncogene.

Entities:  

Mesh:

Year:  1998        PMID: 9865431

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  8 in total

1.  Updated mortality among diverse operating segments of a petroleum company.

Authors:  R J Lewis; A R Schnatter; A M Katz; F S Thompson; N Murray; G Jorgensen; G Thériault
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

2.  Fluorescence in situ hybridization is necessary to detect an association between chromosome aberrations and polycyclic aromatic hydrocarbon exposure in utero and reveals nonrandom chromosome involvement.

Authors:  Kirsti A Bocskay; Manuela A Orjuela; Deliang Tang; Xinhua Liu; Dorothy Warburton; Frederica P Perera
Journal:  Environ Mol Mutagen       Date:  2007-03       Impact factor: 3.216

Review 3.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

4.  Smoking adversely affects survival in acute myeloid leukemia patients.

Authors:  Ramya Varadarajan; Andrea S Licht; Andrew J Hyland; Laurie A Ford; Sheila N J Sait; Annemarie W Block; Maurice Barcos; Maria R Baer; Eunice S Wang; Meir Wetzler
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

5.  The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.

Authors:  Xia Bi; Zachary French; Neil Palmisiano; Kuang-Yi Wen; Lindsay Wilde
Journal:  Ann Hematol       Date:  2022-03-14       Impact factor: 3.673

6.  Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.

Authors:  Ramya Varadarajan; LaurieAnn Ford; Sheila N J Sait; AnneMarie W Block; Maurice Barcos; Paul K Wallace; Nithya Ramnath; Eunice S Wang; Meir Wetzler
Journal:  Leuk Res       Date:  2009-01-31       Impact factor: 3.156

7.  Leukemia-related chromosomal loss detected in hematopoietic progenitor cells of benzene-exposed workers.

Authors:  L Zhang; Q Lan; Z Ji; G Li; M Shen; R Vermeulen; W Guo; A E Hubbard; C M McHale; S M Rappaport; R B Hayes; M S Linet; S Yin; M T Smith; N Rothman
Journal:  Leukemia       Date:  2012-05-30       Impact factor: 11.528

8.  Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.

Authors:  Rekha Chaubey; Sudha Sazawal; Rima Dada; Manoranjan Mahapatra; Renu Saxena
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.